• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
No carbapenem resistance in pneumonia caused by Klebsiella species.肺炎克雷伯菌引起的肺炎中无碳青霉烯类耐药情况。
Medicine (Baltimore). 2015 Feb;94(6):e527. doi: 10.1097/MD.0000000000000527.
2
No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study.在一项为期10年的研究中,与肺炎相关的嗜血杆菌属未出现对环丙沙星的耐药性发展。
BMC Infect Dis. 2015 Nov 13;15:514. doi: 10.1186/s12879-015-1267-3.
3
Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.德国一家大学医院中心10年间肺炎患者中铜绿假单胞菌的抗生素耐药性
PLoS One. 2015 Oct 2;10(10):e0139836. doi: 10.1371/journal.pone.0139836. eCollection 2015.
4
No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli.肺炎克雷伯菌所致肺炎中未出现亚胺培南耐药情况。 需注意,你原文中的“Escherichia coli”表述有误,结合内容推测应该是“Klebsiella pneumoniae”,以上是按照纠正后的内容翻译的。如果按照你提供的原文“Escherichia coli”(大肠杆菌)翻译则为:大肠杆菌所致肺炎中未出现亚胺培南耐药情况。
Medicine (Baltimore). 2015 Jun;94(25):e1020. doi: 10.1097/MD.0000000000001020.
5
[Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].[重症监护病房中的肺炎克雷伯菌感染:与碳青霉烯类耐药性及患者死亡率相关的危险因素]
Mikrobiyol Bul. 2020 Jul;54(3):378-391. doi: 10.5578/mb.69679.
6
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.在斯里兰卡引起尿路感染的产超广谱β-内酰胺酶生物体及其抗生素敏感性模式——一项基于医院的横断面研究。
BMC Infect Dis. 2017 Feb 10;17(1):138. doi: 10.1186/s12879-017-2250-y.
7
[Fatal pneumonia caused by carbapenem resistant Klebsiella pneumoniae].[碳青霉烯类耐药肺炎克雷伯菌所致致命性肺炎]
Ned Tijdschr Geneeskd. 2010;154(45):A2526.
8
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌医院感染的危险因素
South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d.
9
Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors.土耳其一家大学医院中耐碳青霉烯类克雷伯菌属感染的出现:流行病学及危险因素
J Infect Dev Ctries. 2014 Jan 15;8(1):44-9. doi: 10.3855/jidc.3091.
10
Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.碳青霉烯类药物不敏感肺炎克雷伯菌血流感染的危险因素、结局和基因型:中国北方一家大型三级医院的三年回顾性研究。
Infect Dis (Lond). 2018 Jun;50(6):443-451. doi: 10.1080/23744235.2017.1421772. Epub 2018 Jan 5.

引用本文的文献

1
A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against .一项评估奥比沙星和没食子酸丙酯协同作用的药效学研究。 (原文句末不完整,推测完整句子可能是“A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against [某种病菌或情况].” 这里按照正常的翻译逻辑补全了语义)
Front Pharmacol. 2022 Sep 15;13:989395. doi: 10.3389/fphar.2022.989395. eCollection 2022.
2
Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies.成人社区获得性细菌性肺炎的管理:当前抗生素的局限性及未来治疗方法
Lung India. 2019 Nov-Dec;36(6):525-533. doi: 10.4103/lungindia.lungindia_38_19.

本文引用的文献

1
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014.2013 年 11 月至 2014 年 4 月期间,意大利出现了黏菌素耐药性与地方性耐碳青霉烯类肺炎克雷伯菌的双重感染:这是一个迅速演变的问题。
Euro Surveill. 2014 Oct 23;19(42):20939. doi: 10.2807/1560-7917.es2014.19.42.20939.
2
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.肠杆菌科细菌对头孢噻肟和厄他培南的耐药性:改变临床断点的影响
J Infect Dev Ctries. 2014 Mar 13;8(3):289-96. doi: 10.3855/jidc.3335.
3
Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.产碳青霉烯酶肠杆菌科细菌:一项重大公共卫生挑战概述
Med Mal Infect. 2014 Feb;44(2):51-6. doi: 10.1016/j.medmal.2013.11.007. Epub 2013 Dec 18.
4
Analysis of some common pathogens and their drug resistance to antibiotics.分析一些常见病原体及其对抗生素的耐药性。
Pak J Med Sci. 2013 Jan;29(1):135-9. doi: 10.12669/pjms.291.2744.
5
Increased cefepime MIC for enterobacteriacae clinical isolates.肠杆菌科临床分离株对头孢吡肟的最低抑菌浓度增加。
Caspian J Intern Med. 2013 Spring;4(2):654-7.
6
Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae testing susceptible to cefepime by reference methods.产碳青霉烯酶肠杆菌科细菌对头孢吡肟敏感的检测——参考方法。
J Clin Microbiol. 2013 Jul;51(7):2388-90. doi: 10.1128/JCM.00640-13. Epub 2013 Apr 24.
7
Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns.肠杆菌科中的肺炎克雷伯菌碳青霉烯酶:历史、演变和微生物学关注点。
Pharmacotherapy. 2012 May;32(5):399-407. doi: 10.1002/j.1875-9114.2012.01035.x. Epub 2012 Apr 5.
8
Retrospective investigation of the clinical effects of tazobactam/piperacillin and sulbactam/ampicillin on aspiration pneumonia caused by Klebsiella pneumoniae.回顾性研究哌拉西林/他唑巴坦和氨苄西林/舒巴坦治疗肺炎克雷伯菌引起的吸入性肺炎的临床效果。
J Infect Chemother. 2012 Oct;18(5):715-21. doi: 10.1007/s10156-012-0407-6. Epub 2012 Mar 30.
9
Global spread of Carbapenemase-producing Enterobacteriaceae.产碳青霉烯酶肠杆菌科的全球传播。
Emerg Infect Dis. 2011 Oct;17(10):1791-8. doi: 10.3201/eid1710.110655.
10
Diagnosis and management of community-acquired pneumonia in adults.成人社区获得性肺炎的诊断与管理。
Am Fam Physician. 2011 Jun 1;83(11):1299-306.

肺炎克雷伯菌引起的肺炎中无碳青霉烯类耐药情况。

No carbapenem resistance in pneumonia caused by Klebsiella species.

作者信息

Yayan Josef, Ghebremedhin Beniam, Rasche Kurt

机构信息

From the HELIOS Clinic Wuppertal, Witten/Herdecke University, Wuppertal, Germany.

出版信息

Medicine (Baltimore). 2015 Feb;94(6):e527. doi: 10.1097/MD.0000000000000527.

DOI:10.1097/MD.0000000000000527
PMID:25674753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4602765/
Abstract

Klebsiella species are a common cause of community- and nosocomial-acquired pneumonia. Antibiotic resistance to the class of carbapenem in patients with pneumonia caused by Klebsiella species is unusual. New studies report carbapenem resistance in patients with pneumonia caused by Klebsiella species.This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by Klebsiella species.The data of all patients with community- and nosocomial-acquired pneumonia caused by Klebsiella species were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within the study period 2004 to 2014. An antibiogram was created from all of the study patients with pneumonia caused by Klebsiella species. Sensitivity and resistance profiles were performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by Klebsiella species. All demographic, clinical, and laboratory data of all of the patients with pneumonia caused by Klebsiella species were collected from the patients' records.During the study period of January 1, 2004, to August 12, 2014, 149 patients were identified with community- and nosocomial-acquired pneumonia affected by Klebsiella species. These patients had a mean age of 70.6 ± 13 (107 [71.8%, 95% CI 64.6%-79%] men and 42 [28.2%, 95% CI 21%-35.4%] women). In all of the patients with pneumonia caused by Klebsiella species, there was resistance to ampicillin (P < 0.0001). Many patients with pneumonia caused by Klebsiella species (75.3%) also showed resistance to piperacillin (P < 0.0001). However, no patients with pneumonia caused by Klebsiella species showed resistance to imipenem or meropenem (P < 0.0001).Antibiotic resistance to the antibiotic class of carbapenem was not detected in patients with pneumonia caused by Klebsiella species.

摘要

克雷伯菌属是社区获得性肺炎和医院获得性肺炎的常见病因。由克雷伯菌属引起的肺炎患者对碳青霉烯类抗生素耐药并不常见。新研究报道了由克雷伯菌属引起的肺炎患者出现碳青霉烯类耐药情况。本文回顾性研究了由克雷伯菌属引起的社区获得性肺炎和医院获得性肺炎患者的抗生素耐药情况。在2004年至2014年的研究期间,从德国伍珀塔尔市维滕/黑尔德克大学HELIOS诊所的医院病历中收集了所有由克雷伯菌属引起的社区获得性肺炎和医院获得性肺炎患者的数据。为所有由克雷伯菌属引起的肺炎研究患者创建了一份抗菌谱。对一直用于治疗由克雷伯菌属引起的肺炎患者的不同抗生素进行了敏感性和耐药性分析。从患者记录中收集了所有由克雷伯菌属引起的肺炎患者的所有人口统计学、临床和实验室数据。在2004年1月1日至2014年8月12日的研究期间,确定了149例受克雷伯菌属影响的社区获得性肺炎和医院获得性肺炎患者。这些患者的平均年龄为70.6±13岁(男性107例[71.8%,95%可信区间64.6%-79%],女性42例[28.2%,95%可信区间21%-35.4%])。在所有由克雷伯菌属引起的肺炎患者中,对氨苄西林耐药(P<0.0001)。许多由克雷伯菌属引起的肺炎患者(75.3%)也对哌拉西林耐药(P<0.0001)。然而,没有由克雷伯菌属引起的肺炎患者对亚胺培南或美罗培南耐药(P<0.0001)。在由克雷伯菌属引起的肺炎患者中未检测到对碳青霉烯类抗生素的耐药情况。